WS Management Lllp Has $7.80 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• WS Management Lllp reduced its stake in GE HealthCare Technologies by 20.8%, selling 25,325 shares, which now makes up 0.9% of its total holdings.
• Analysts have a consensus rating of "Moderate Buy" for GE HealthCare Technologies, with an average price target of $88.55.
• GE HealthCare Technologies reported a quarterly EPS of $1.06, exceeding estimates and reflecting a 3.5% year-over-year revenue growth to $5 billion.

WS Management Lllp cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 20.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,675 shares of the company's stock after selling 25,325 shares during the quarter. GE HealthCare Technologies makes up approximately 0.9% of WS Management Lllp's portfolio, making the stock its 17th largest holding. WS Management Lllp's holdings in GE HealthCare Technologies were worth $7,803,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Breakwater Capital Group acquired a new stake in GE HealthCare Technologies in the 1st quarter valued at approximately $210,000. Bessemer Group Inc. grew its stake in shares of GE HealthCare Technologies by 24.3% during the first quarter. Bessemer Group Inc. now owns 6,671 shares of the company's stock worth $538,000 after purchasing an additional 1,306 shares in the last quarter. Flagship Harbor Advisors LLC boosted its stake in GE HealthCare Technologies by 17.4% in the first quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company's stock valued at $278,000 after acquiring an additional 511 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of GE HealthCare Technologies by 23.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company's stock worth $4,105,000 after buying an additional 9,769 shares during the period. Finally, Farther Finance Advisors LLC raised its holdings in GE HealthCare Technologies by 52.7% during the first quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company's stock worth $357,000 after purchasing an additional 1,550 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Up 0.0%

NASDAQ GEHC traded up $0.01 during trading on Friday, hitting $73.73. 1,982,987 shares of the company traded hands, compared to its average volume of 3,970,315. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The business has a fifty day simple moving average of $74.18 and a 200 day simple moving average of $74.85. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $33.66 billion, a P/E ratio of 15.11, a PEG ratio of 2.84 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the business posted $1.00 earnings per share. The firm's revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were paid a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is 2.87%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a report on Thursday, May 1st. Citigroup boosted their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. Morgan Stanley decreased their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Finally, Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $88.55.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.